Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$256 Mln
Revenue (TTM)
$0 Mln
Net Profit (TTM)
$7 Mln
ROE
0 %
ROCE
-- %
P/E Ratio
29.2
P/B Ratio
1.3
Industry P/E
--
EV/EBITDA
0
Div. Yield
0 %
Debt to Equity
--
Book Value
$39
EPS
$3.7
Face value
--
Shares outstanding
20,000,000
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
| 1.8 | -0.1 | 0.8 | 4.5 | -- | -- | -- |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2022
|
|---|---|
|
Orion Biotech Opportunities Corp (ORIA)
| 3.9 |
|
BSE Sensex
| 4.4 |
|
BSE Sensex
| 4.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Orion Biotech Opportunities Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company... intends to acquire businesses in the biotechnology and life sciences sectors. Orion Biotech Opportunities Corp. was incorporated in 2021 and is based in New York, New York. Read more
CEO & Director
Mr. Zuie-Chin Huang M.B.A.
CEO & Director
Mr. Zuie-Chin Huang M.B.A.
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Orion Biotech Opportunities Corp (ORIA) is $10.23 (NASDAQ) as of 17-May-2023 09:30 EDT. Orion Biotech Opportunities Corp (ORIA) has given a return of 4.49% in the last 1 years.
The P/E ratio of Orion Biotech Opportunities Corp (ORIA) is 29.23 times as on 17-May-2023.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
2.73
|
0.26
|
|
2021
|
-58.92
|
0.26
|
|
2022
|
2.73
|
0.26
|
|
2021
|
-58.92
|
0.26
|
The 52-week high and low of Orion Biotech Opportunities Corp (ORIA) are Rs -- and Rs -- as of 02-Apr-2026.
Orion Biotech Opportunities Corp (ORIA) has a market capitalisation of $ 256 Mln as on 17-May-2023. As per SEBI classification, it is a company.
Before investing in Orion Biotech Opportunities Corp (ORIA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.